TH1902 in Patients With Advanced Solid Tumors

Clinical trial NCT04706962 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04706962
Sponsor: Theratechnologies
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor TNBC - Triple-Negative Breast Cancer Hormone Receptor-positive Breast Cancer Epithelial Ovarian Cancer Endometrial Cancer Cutaneous Melanoma Thyroid Cancer Small-cell Lung Cancer Prostate Cancer SORT1+ Cancers

Start date: 2021-03-04
Primary completion: 2025-12-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.